A prospective study on the prevalence of at‐risk MASH in patients with type 2 diabetes mellitus in the United States

Documenti analoghi

• The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
  di: Lana Bridi, et al.
  Pubblicazione: (2024)
• Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study
  di: Harris Siddiqi, et al.
  Pubblicazione: (2024)
• Clinical Trial: Semaglutide Versus Placebo in NIT ‐Assessed MASH —A Multicenter Randomised Placebo‐Controlled Trial ( SAMARA )
  di: Veeral Ajmera, et al.
  Pubblicazione: (2026)
• Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study
  di: Federica Tavaglione, et al.
  Pubblicazione: (2025)
• Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States
  di: Kelly Torosian, et al.
  Pubblicazione: (2025)